These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17375350)

  • 1. Nesiritide for the treatment of pulmonary hypertension and cor pulmonale in an infant.
    Reynolds EW; Conely ET; Vranicar M
    Pediatr Cardiol; 2007; 28(3):229-33. PubMed ID: 17375350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nesiritide for pulmonary arterial hypertension with decompensated cor pulmonale.
    Kingman MS; Thompson BS; Newkirk T; Torres F
    Prog Cardiovasc Nurs; 2005; 20(4):168-72. PubMed ID: 16276140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nesiritide in pulmonary hypertension.
    Kurian DC; Wagner IJ; Klapholz M
    Chest; 2004 Jul; 126(1):302-5. PubMed ID: 15249476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nesiritide therapy in a term neonate with renal disease.
    Moffett BS; Jefferies JL; Rossano J; Towbin JA
    Pharmacotherapy; 2006 Feb; 26(2):281-4. PubMed ID: 16466334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary experience with nesiritide in pediatric patients less than 12 months of age.
    Ryan A; Rosen DA; Tobias JD
    J Intensive Care Med; 2008; 23(5):321-8. PubMed ID: 18603536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility of medically unresponsive pulmonary hypertension with nesiritide in a cardiac transplant recipient.
    Bhat G; Costea A
    ASAIO J; 2003; 49(5):608-10. PubMed ID: 14524574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
    Kasian GF; Ninan A; Duncan WJ; Bingham WT; Mersal A; Tyrrell MJ; Sankaran K
    Can J Cardiol; 1988 May; 4(4):181-4. PubMed ID: 3395914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoprostenol and nesiritide in pulmonary hypertension.
    Rubin LJ
    Chest; 2005 May; 127(5):1870. PubMed ID: 15888882
    [No Abstract]   [Full Text] [Related]  

  • 9. Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure.
    O'Dell KM; Kalus JS; Kucukarslan S; Czerska B
    Am J Health Syst Pharm; 2005 Mar; 62(6):606-9. PubMed ID: 15757881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension.
    Khush KK; De Marco T; Vakharia KT; Harmon C; Fineman JR; Chatterjee K; Michaels AD
    J Card Fail; 2006 Sep; 12(7):507-13. PubMed ID: 16952783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension and chronic cor pulmonale in COPD.
    Shujaat A; Minkin R; Eden E
    Int J Chron Obstruct Pulmon Dis; 2007; 2(3):273-82. PubMed ID: 18229565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nesiritide during extracorporeal membrane oxygenation.
    Smith T; Rosen DA; Russo P; Berkenbosch JW; Gustafson RA; Siu BL; Rosen KR; Tobias JD
    Paediatr Anaesth; 2005 Feb; 15(2):152-7. PubMed ID: 15675934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide as bridge to multi-organ transplantation: a case report.
    Cochrane AB; Fedson SE; Cronin DC
    Transplant Proc; 2007; 39(1):308-10. PubMed ID: 17275531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension.
    Kelesidis I; Mazurek JA; Saeed W; Chaudhari R; Velankar P; Zolty R
    Congest Heart Fail; 2012; 18(1):18-24. PubMed ID: 22277173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure.
    Baroletti SA; Wahlstrom HD
    Pharmacotherapy; 2004 Nov; 24(11):1634-7. PubMed ID: 15537565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.